📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Alkermes Plc

Common Name
Alkermes
Country
Ireland
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,800
Ticker
ALKS
Exchange
NASDAQ/NGS
Description
Alkermes plc is a prominent biopharmaceutical company focusing on the development and commercialization of innovative medicines aimed at addressing unmet medical needs in major therapeutic areas such ...

Alkermes's Financial Statements Preview

Below are the financial statements of Alkermes, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in thousands of USD
2024
2023
2022
Revenues———
Product sales, net
1,083,534a
919,998a
777,552a
Manufacturing and royalty revenues
474,095a
743,388a
331,983a
License revenue
0a
0a
2,000a
Research and development revenue
3a
19a
260a
Total revenues
1,557,632a
1,663,405a
1,111,795a
Expenses———
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)
-245,331a
-253,037a
-218,068a
Research and development
-245,326a
-270,806a
-272,702a
Selling, general and administrative
-645,238a
-689,751a
-590,751a
Amortization of acquired intangible assets
-1,101a
-35,689a
-36,363a
Total expenses
-1,136,996a
-1,249,283a
-1,117,884a
Operating income from continuing operations
420,636a
414,122a
-6,089a
Other income (expense), net———
Interest income
42,450a
30,854a
7,629a
Interest expense
-22,578a
-23,032a
-13,040a
Change in the fair value of contingent consideration
0a
0a
-21,750a
Other income (expense), net
3,242a
-425a
2,122a
Total other income (expense), net
23,114a
7,397a
-25,039a
Income (loss) before income taxes
443,750a
421,519a
-31,128a
Income tax provision (benefit)
71,612a
-97,638a
2,024a
Net income (loss) from continuing operations
372,138a
519,157a
-33,152a
Loss from discontinued operations, net of tax
-5,068a
-163,400a
-125,115a
Net income (loss)
367,070a
355,757a
-158,267a
Download Data

Verified Sources Behind Alkermes’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Alkermes’s data sources below and access millions more through our Disclosure Search.

a. Alkermes's Financial Report 2024
a. Alkermes's Financial Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?